drugset / Trial / NCT00002216

A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment

NCT00002216

Completed Glaxo Wellcome
Open-labelTreatment

Summary

The purpose of this study is to compare 2 combination drug therapies in HIV-infected patients who have never received anti-HIV treatment.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Abacavir Other / unclassified
Subject Amprenavir Other / unclassified
Subject Nelfinavir Other / unclassified
Background Lamivudine/Zidovudine Unknown